In: Microbiology Spectrum, 2018, vol. 6, no. 4, p. -
Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly observed in human but also in veterinary medicine worldwide. E. coli is intrinsically susceptible to almost all clinically relevant antimicrobial agents, but this bacterial species has a great capacity to accumulate resistance genes, mostly through horizontal gene transfer. The most problematic...
|
In: European Journal of Clinical Microbiology and Infectious Diseases, 2005, vol. 24, no. 3, p. 233-235
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2017, p. 1–5
Multidrug-resistant (MR) Gram-negative (GN) pathogens pose a major and growing threat for healthcare systems, as therapy of infections is often limited due to the lack of available systemic antibiotics. Well-tolerated antiseptics, such as octenidine dihydrochloride (OCT), may be a very useful tool in infection control to reduce the dissemination of MRGN. This study aimed to investigate the...
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2017, p. 1–9
The novel siderophore cephalosporin cefiderocol (S-649266) with potent activity against Gram-negative pathogens was recently developed (Shionogi & Co., Ltd.). Here, we evaluated the activity of this new molecule and comparators against a collection of previously characterized Gram-negative isolates using broth microdilution panels. A total of 753 clinical multidrug-resistant Gram-negative...
|
In: Journal of Infectious Diseases, 1991, vol. 163, no. 4, p. 769-772
|
In: Epidemiology and Infection, 2011, vol. 139, no. 10, p. 1610-1620
|
In: Journal of Materials Research, 2002, vol. 17, no. 12, p. 3222-3229
|
In: Journal of Antimicrobial Chemotherapy, 2011, vol. 66, no. 10, p. 2248-2254
|
In: International Journal of Antimicrobial Agents, 2016, vol. 47, no. 1, p. 102–103
|
In: Antimicrobial Agents and Chemotherapy, 2014, vol. 58, no. 7, p. 3762–3767
We designed a study to describe the characteristics of sequence type 131 (ST131) lineages, including the H30-Rx sublineage, among a global collection of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from 9 countries collected from 2000 to 2011. A total of 240 nonrepeat isolates from Canada, the United States, Brazil, the Netherlands, France, the United Arab...
|